Plunkett Research Online: Titan Pharmaceuticals Inc

TITAN PHARMACEUTICALS INC (TTNP:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Titan Pharmaceuticals, Inc. is a biopharmaceutical company that develops proprietary therapeutics for the treatment of central nervous system disorders, cardiovascular disease, bone disease and other disorders. The company’s main products are Probuphine and ProNeura. Probuphine is a slow release i.....



Titan Pharmaceuticals Inc
Ticker: TTNP
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 650 244-4990
Fax: 650 244-4956
Address: 400 Oyster Point Boulevard
Suite 505
South San Francisco, CA 94080 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Central Nervous System, Cardiovascular & Bone Diseases Therapeutics
Drug Delivery Systems
ContactsDescription
Sunil BhonsleCEO/CFO/Director/President
Marc RubinChairman of the Board/Director
See More
Titan Pharmaceuticals, Inc. is a biopharmaceutical company that develops proprietary therapeutics for the treatment of central nervous system disorders, cardiovascular disease, bone disease and other disorders. The company’s main products are Probuphine and ProNeura. Probuphine is a slow release i.....See More See More

Auditor: OUM & Co. LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Probuphine
ProNeura
Fanapt
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: